- Home
- GILD vs HCA Comparison
GILD vs HCA Comparison
Compare GILD & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- HCA
- Stock Information
- Founded
- GILD 1987
- HCA 1968
- Country
- GILD United States
- HCA United States
- Employees
- GILD N/A
- HCA N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- HCA Hospital/Nursing Management
- Sector
- GILD Health Care
- HCA Health Care
- Exchange
- GILD Nasdaq
- HCA Nasdaq
- Market Cap
- GILD 113.0B
- HCA 93.8B
- IPO Year
- GILD 1992
- HCA N/A
- Fundamental
- Price
- GILD $92.98
- HCA $303.99
- Analyst Decision
- GILD Buy
- HCA Buy
- Analyst Count
- GILD 26
- HCA 15
- Target Price
- GILD $96.71
- HCA $381.29
- AVG Volume (30 Days)
- GILD 6.4M
- HCA 1.4M
- Earning Date
- GILD 02-11-2025
- HCA 01-28-2025
- Dividend Yield
- GILD 3.38%
- HCA 0.88%
- EPS Growth
- GILD N/A
- HCA 9.31
- EPS
- GILD 0.10
- HCA 22.31
- Revenue
- GILD $28,299,000,000.00
- HCA $69,621,000,000.00
- Revenue This Year
- GILD $6.54
- HCA $9.61
- Revenue Next Year
- GILD N/A
- HCA $6.08
- P/E Ratio
- GILD $937.76
- HCA $13.39
- Revenue Growth
- GILD 3.31
- HCA 10.23
- 52 Week Low
- GILD $62.07
- HCA $265.76
- 52 Week High
- GILD $98.90
- HCA $417.14
- Technical
- Relative Strength Index (RSI)
- GILD 52.30
- HCA 19.25
- Support Level
- GILD $90.27
- HCA $310.50
- Resistance Level
- GILD $93.59
- HCA $317.08
- Average True Range (ATR)
- GILD 2.12
- HCA 7.01
- MACD
- GILD -0.21
- HCA -0.50
- Stochastic Oscillator
- GILD 50.91
- HCA 5.40
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.